Brief: Elicera Therapeutics Q1 Operating Loss SEK 5.1 Mln
21/04/2026 07:07
April 21 (Reuters) - Elicera Therapeutics AB ELIC.ST: Q1 ADJUSTED EPS SEK -0.1 Q1 OPERATING LOSS AMOUNTED TO SEK -5,116,779 Q1 LOSS FOR PERIOD AMOUNTED TO SEK -5,060,060 Source text: ID:nWkr6vCtlJ Further company coverage: ELIC.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Elicera Therapeutics AB
See all newsBrief: Nomination Committee Proposes Margareth Jorvid As Chair Of Elicera Board
Brief: Elicera Therapeutics Carries Out Rights Issue Of About SEK 73 Mln
Sweden's Elicera Therapeutics Q1 loss narrows, reports positive clinical progress
Brief: Elicera Therapeutics Q1 Operating Loss SEK 5.1 Mln
Brief: Elicera Therapeutics Gets Notice Of Allowance For Japanease Patent